跳至主要内容
临床试验/JPRN-UMIN000024794
JPRN-UMIN000024794已完成未知

Efficacy of bevacizumab on brain radiation necrosis after irradiation for brain diseases. - Efficacy of bevacizumab on radiation necrosis

Osaka Medical College0 个研究点目标入组 30 人开始时间: 2016年11月11日最近更新:
适应症

试验速览

阶段
未知
状态
已完成
入组人数
30

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
16years-old 至 ot applicable(—)
性别
All

入选标准

  • 未提供

排除标准

  • Patients had hemorrhagic diseases. Patients had allergy for bevacizumab. Patients were suspected tumor recurrence. Pregnant patients.

研究者

相似试验

已完成
2 期
Effect of Bevacizumab on Radiation-induced Brain Necrosis in Patients With Nasopharyngeal CarcinomaAdverse Effect of Radiation TherapyBrain NecrosisNasopharyngeal Carcinoma
NCT01621880Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University112
招募中
2 期
Effect of Bevacizumab on Asymptomatic Radiotherapy-induced Brain InjuryBrain Injuries
NCT05303259Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University204
已完成
不适用
Study on effectiveness of bevacizumab for treatment of radiation necrosis in the brain caused by gamma knife radiation therapyRadiation necrosis in the brain
JPRN-UMIN000034959Department of Neurology, Aizawa Hospital5
已完成
2 期
Bevacizumab in Reducing CNS Side Effects in Patients Who Have Undergone Radiation Therapy to the Brain for Primary Brain Tumor, Meningioma, or Head and Neck CancerAdult Anaplastic AstrocytomaAdult Anaplastic EpendymomaAdult Anaplastic MeningiomaAdult Anaplastic OligodendrogliomaAdult Brain Stem GliomaAdult Central Nervous System Germ Cell TumorAdult Choroid Plexus TumorAdult Diffuse AstrocytomaAdult EpendymomaAdult Grade II MeningiomaAdult Grade III MeningiomaAdult Malignant HemangiopericytomaAdult Mixed GliomaAdult OligodendrogliomaAdult Papillary MeningiomaAdult PineocytomaMalignant NeoplasmMeningeal MelanocytomaRadiation ToxicityRecurrent Adenoid Cystic Carcinoma of the Oral CavityRecurrent Adult Brain TumorRecurrent Basal Cell Carcinoma of the LipRecurrent Esthesioneuroblastoma of the Paranasal Sinus and Nasal CavityRecurrent Inverted Papilloma of the Paranasal Sinus and Nasal CavityRecurrent Lymphoepithelioma of the NasopharynxRecurrent Lymphoepithelioma of the OropharynxRecurrent Midline Lethal Granuloma of the Paranasal Sinus and Nasal CavityRecurrent Mucoepidermoid Carcinoma of the Oral CavityRecurrent Salivary Gland CancerRecurrent Squamous Cell Carcinoma of the HypopharynxRecurrent Squamous Cell Carcinoma of the LarynxRecurrent Squamous Cell Carcinoma of the Lip and Oral CavityRecurrent Squamous Cell Carcinoma of the NasopharynxRecurrent Squamous Cell Carcinoma of the OropharynxRecurrent Squamous Cell Carcinoma of the Paranasal Sinus and Nasal CavityRecurrent Verrucous Carcinoma of the LarynxRecurrent Verrucous Carcinoma of the Oral CavityStage I Adenoid Cystic Carcinoma of the Oral CavityStage I Basal Cell Carcinoma of the LipStage I Esthesioneuroblastoma of the Paranasal Sinus and Nasal CavityStage I Inverted Papilloma of the Paranasal Sinus and Nasal CavityStage I Lymphoepithelioma of the NasopharynxStage I Lymphoepithelioma of the OropharynxStage I Midline Lethal Granuloma of the Paranasal Sinus and Nasal CavityStage I Mucoepidermoid Carcinoma of the Oral CavityStage I Salivary Gland CancerStage I Squamous Cell Carcinoma of the HypopharynxStage I Squamous Cell Carcinoma of the LarynxStage I Squamous Cell Carcinoma of the Lip and Oral CavityStage I Squamous Cell Carcinoma of the NasopharynxStage I Squamous Cell Carcinoma of the OropharynxStage I Squamous Cell Carcinoma of the Paranasal Sinus and Nasal CavityStage I Verrucous Carcinoma of the LarynxStage I Verrucous Carcinoma of the Oral CavityStage III Adenoid Cystic Carcinoma of the Oral CavityStage III Basal Cell Carcinoma of the LipStage III Esthesioneuroblastoma of the Paranasal Sinus and Nasal CavityStage III Inverted Papilloma of the Paranasal Sinus and Nasal CavityStage III Lymphoepithelioma of the NasopharynxStage III Midline Lethal Granuloma of the Paranasal Sinus and Nasal CavityStage III Mucoepidermoid Carcinoma of the Oral CavityStage III Salivary Gland CancerStage III Squamous Cell Carcinoma of the HypopharynxStage III Squamous Cell Carcinoma of the LarynxStage III Squamous Cell Carcinoma of the Lip and Oral CavityStage III Squamous Cell Carcinoma of the NasopharynxStage III Squamous Cell Carcinoma of the OropharynxStage III Squamous Cell Carcinoma of the Paranasal Sinus and Nasal CavityStage III Verrucous Carcinoma of the LarynxStage III Verrucous Carcinoma of the Oral CavityStage IV Adenoid Cystic Carcinoma of the Oral CavityStage IV Basal Cell Carcinoma of the LipStage IV Esthesioneuroblastoma of the Paranasal Sinus and Nasal CavityStage IV Inverted Papilloma of the Paranasal Sinus and Nasal CavityStage IV Lymphoepithelioma of the NasopharynxStage IV Lymphoepithelioma of the OropharynxStage IV Midline Lethal Granuloma of the Paranasal Sinus and Nasal CavityStage IV Mucoepidermoid Carcinoma of the Oral CavityStage IV Salivary Gland CancerStage IV Squamous Cell Carcinoma of the HypopharynxStage IV Squamous Cell Carcinoma of the LarynxStage IV Squamous Cell Carcinoma of the Lip and Oral CavityStage IV Squamous Cell Carcinoma of the NasopharynxStage IV Squamous Cell Carcinoma of the OropharynxStage IV Squamous Cell Carcinoma of the Paranasal Sinus and Nasal CavityStage IV Verrucous Carcinoma of the LarynxStage IV Verrucous Carcinoma of the Oral Cavity
NCT00492089National Cancer Institute (NCI)11
已完成
1 期
Phase 1 study of chemoradiation with bevacizumab as preoperative treatment in locally advanced rectal cancer.ocally advanced rectal cancer
JPRN-UMIN000008452Department of Gastrointestinal and Paediatric Surgery Division of Reparative Medicine Institute of Life Sciences Mie University Graduate School of Medicine12
Efficacy of bevacizumab on brain radiation necrosis... | 临床试验